Capital allocation in life sciences
Search documents
Royalty Pharma (NasdaqGS:RPRX) FY Conference Transcript
2026-01-13 18:47
Royalty Pharma (NasdaqGS:RPRX) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsChris Schott - Managing DirectorPablo Legorreta - Founder & CEONone - Company RepresentativeConference Call ParticipantsNone - AnalystChris SchottGood morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Royalty Pharma today. It's a really unique business in our view, a company that's helping finance a lot of the innovation that's occurring across the biopharma space. From the co ...